11:30 AM EDT, 09/17/2026 (MT Newswires) -- Biosergen (BIOSGN.ST) secured approval to delist from Nasdaq First North Growth Market, with its final trading day set for Oct. 21, according to a Thursday release. The application follows the biotechnology company's planned merger with life science investor Flerie (FLERIE.ST), which is conditional on the Swedish Companies Registration Office's approval, expected around Oct. 15. Registration is set to follow on Oct. 23.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.